50 research outputs found
N-terminal pro-brain natriuretic peptide is associated with a future diagnosis of cancer in patients with coronary artery disease
Objective
Several papers have reported elevated plasma levels of natriuretic peptides in patients with
a previous diagnosis of cancer. We have explored whether N-terminal pro-brain natriuretic
peptide (NT-proBNP) plasma levels predict a future diagnosis of cancer in patients with coronary
artery disease (CAD).
Methods
We studied 699 patients with CAD free of cancer. At baseline, NT-proBNP, galectin-3,
monocyte chemoattractant protein-1, soluble tumor necrosis factor-like weak inducer of apoptosis,
high-sensitivity C-reactive protein, and high-sensitivity cardiac troponin I plasma
levels were assessed. The primary outcome was new cancer diagnosis. The secondary outcome
was cancer diagnosis, heart failure requiring hospitalization, or death.
Results
After 2.15±0.98 years of follow-up, 24 patients developed cancer. They were older (68.5
[61.5, 75.8] vs 60.0 [52.0, 72.0] years; p=0.011), had higher NT-proBNP (302.0 [134.8,
919.8] vs 165.5 [87.4, 407.5] pg/ml; p=0.040) and high-sensitivity C-reactive protein (3.27
[1.33, 5.94] vs 1.92 [0.83, 4.00] mg/L; p=0.030), and lower triglyceride (92.5 [70.5, 132.8] vs
112.0 [82.0, 157.0] mg/dl; p=0.044) plasma levels than those without cancer. NT-proBNP
(Hazard Ratio [HR]=1.030; 95% Confidence Interval [CI]=1.008-1.053; p=0.007) and
triglyceride levels (HR=0.987; 95%CI=0.975-0.998; p=0.024) were independent predictors
of a new cancer diagnosis (multivariate Cox regression analysis). When patients in
whom the suspicion of cancer appeared in the first one-hundred days after blood extraction
were excluded, NT-proBNP was the only predictor of cancer (HR=1.061; 95%
CI=1.034-1.088; p<0.001). NT-proBNP was an independent predictor of cancer, heart failure,
or death (HR=1.038; 95%CI=1.023-1.052; p<0.001) along with age, and use of insulin
and acenocumarol.
Conclusions
NT-proBNP is an independent predictor of malignancies in patients with CAD. New studies
in large populations are needed to confirm these findingsThis work was supported by grants from
Fondo de Investigaciones Sanitarias (PI05/0451,
PI05/1497,PI05/2475, PI05/1043, PS09/01405, PI10/
00072, and PI10/0234, PI14/1567, Programa de
Estabilización to LBC); Spanish Society of Cardiology
and Spanish Heart Foundation; Spanish Society of
Arteriosclerosis; RECAVA (RD06/0014/0035, www.
recava.com); Fundación Lilly; and Instituto de Salud
Carlos III FEDER (FJD biobank: RD09/0076/00101)
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors
AbstractBackgroundPatients with coronary heart disease (CHD) without classical cardiovascular risk factors (CRFs) are uncommon, and their profile has not been thoroughly studied. In CHD patients, we have assessed the differences in several biomarkers between those with and without CRF.MethodsWe studied 704 patients with CHD, analyzing plasma levels of biomarkers related to inflammation, thrombosis, renal damage, and heart failure: high-sensitivity C-reactive protein (hs-CRP), monocyte chemoattractant protein-1 (MCP-1), galectin-3, N-terminal fragment of brain natriuretic peptide (NT-pro-BNP), calcidiol (vitamin D metabolite), fibroblast growth factor-23 (FGF-23), parathormone, and phosphate.ResultsTwenty patients (2.8%) exhibited no CRFs. Clinical variables were well balanced in both groups, with the logical exceptions of no use of antidiabetic drugs, lower triglyceride and glucose, and higher high-density lipoprotein cholesterol in no-CRF patients.No-CRF patients showed lower hs-CRP (2.574±3.120 vs. 4.554±9.786mg/L; p=0.018), MCP-1 (114.75±36.29 vs. 143.56±65.37pg/ml; p=0.003), and FGF-23 (79.28±40.22 vs. 105.17±156.61RU/ml; p=0.024), and higher calcidiol (23.66±9.12 vs. 19.49±8.18ng/ml; p=0.025) levels. At follow-up, 10.0% vs. 11.0% patients experienced acute ischemic event, heart failure, or death in the non-CRF and CRF groups, respectively (p=0.815, log-rank test). The limited number of non-CRF patients may have influenced this finding. A Cox regression analysis in the whole population showed that high calcidiol, and low MCP-1 and FGF-23 plasma levels are associated with a better prognosis.ConclusionsCHD patients without CRFs show a favorable biomarker profile in terms of inflammation and mineral metabolism. Further studies are needed to investigate whether this difference translates into a better prognosis
Luminescence Sensors Applied to Water Analysis of Organic Pollutants—An Update
The development of chemical sensors for environmental analysis based on fluorescence, phosphorescence and chemiluminescence signals continues to be a dynamic topic within the sensor field. This review covers the fundamentals of this type of sensors, and an update on recent works devoted to quantifying organic pollutants in environmental waters, focusing on advances since about 2005. Among the wide variety of these contaminants, special attention has been paid polycyclic aromatic hydrocarbons, pesticides, explosives and emerging organic pollutants. The potential of coupling optical sensors with multivariate calibration methods in order to improve the selectivity is also discussed
Valor de los registros unipolares durante la conducción retrógrada a través de vías accesorias auriculoventriculares
Tesis doctoral inédita leída el 25-11-1988 en la Universidad Autónoma de Madrid, Facultad de Medicina, Departamento de Medicina Preventiva y Salud Públic
Confounding factors leading to misdiagnosing ventricular tachycardia as supraventricular in the emergency room
Studies conducted during the last 50 years have proposed electrocardiographic criteria and algorithms to determine if a wide QRS tachycardia is ventricular or supraventricular in origin. Sustained ventricular tachycardia is an uncommon reason for consultation in the emergency room. The latter and the complexity of available electrocardiographic diagnostic criteria and algorithms result in frequent misdiagnoses. Good hemodynamic tolerance of tachycardia in the supine position does not exclude its ventricular origin. Although rare, ventricular tachycardia in patients with and without structural heart disease may show a QRS duration <120 ms. Interruption of tachycardia by coughing, carotid sinus massage, Valsalva maneuver, or following the infusion of adenosine or verapamil should not discard the ventricular origin of the arrhythmia. In patients with regular, uniform, sustained broad QRS tachycardia, the presence of structural heart disease or A-V dissociation strongly suggest its ventricular origin. Occasionally, ventricular tachycardia can present with AV dissociation without this being evident on the 12-lead ECG. Cardiac auscultation, examination of the jugular venous pulse, and arterial pulse palpation provide additional clues for identifying A-V dissociation during tachycardia. This paper does not review the electrocardiographic criteria for categorizing tachycardia as ventricular but rather why emergency physicians misdiagnose these patients